Nitric BioTherapeutics, Inc. President Frank J. McCaney Named Ernst & Young Entrepreneur of the Year 2009® Award Finalist in Greater Philadelphia
Philadelphia, PA June 18, 2009 – Nitric BioTherapeutics, Inc. today announced that President Frank J. McCaney is a finalist for the Ernst & Young Entrepreneur of the Year® 2009 Award for Greater Philadelphia. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Mr. McCaney was selected as a finalist from nearly 40 nominations by a panel of independent judges. Award winners will be announced at a special gala event on June 18, 2009 at the Philadelphia Loews Hotel.
The Ernst & Young Entrepreneur of the Year awards program celebrates its 23rd anniversary this year. The program has expanded to recognize business leaders in over 135 cities in 50 countries throughout the world.
Regional award winners are eligible for consideration for the Ernst & Young LLP Entrepreneur of the Year national program. Award winners in several national categories, as well as the overall national Ernst & Young Entrepreneur of the Year award winner, will be announced at the annual awards gala in Palm Springs, California on November 14, 2009. The awards are the culminating event of the Ernst & Young Strategic Growth Forum, the nation’s most prestigious gathering of high-growth, market-leading companies.
Founded and produced by Ernst & Young LLP, the Entrepreneur of the Year awards are pleased to have the Ewing Marion Kauffman Foundation and SAP America as national sponsors.
In Greater Philadelphia, sponsors include Ballard Spahr, Morgan Lewis and Pepper Hamilton.
About Nitric BioTherapeutics, Inc.
Nitric BioTherapeutics is a venture backed biopharmaceutical and medical device company developing treatments for the healing of chronic wounds and the resolution of infections using topical application of nitric oxide gas (gNO). Nitric oxide has significant broad spectrum antimicrobial effects, including potent effects against drug-resistant bacterial strains, as well as effects on inflammation, collagen production and blood flow. Nitric Bio is pursuing human clinical work in a number of indications as an anti-infective agent for treating or preventing fungal, bacterial and parasitic infections. More information on the company can be found at www.nitricbio.com.
About Ernst & Young’s Entrepreneur of the Year® Awards Program
Ernst & Young’s Entrepreneur of the Year® Award is the world’s most prestigious business award for entrepreneurs. The award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, the Ernst & Young Entrepreneur Of The Year® award celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.
# # #